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The epicardium has been recognized as a source of cardiovascular progenitors during embryogenesis and
postnatal life. In this issue of Cell Stem Cell, Chong et al. (2011) identify cardiac CFU-Fs as cardiac-resident
cells of epicardial origin with broad multilineage differentiation potential.Bone marrow cells with potential to form
colonies composed of fibroblastoid cells
(colony-forming-unit fibroblasts; CFU-Fs)
were identified over 40 years ago (Frie-
denstein et al., 1970). Because these cells
were capable of long-term expansion
in vitro and differentiation to multiple
connective cell types, they were defined
as mesenchymal stem cells (MSCs) (Ca-
plan, 1991). Subsequently, MSCs have
been isolated from almost all types of
tissues, including adipose tissue and
umbilical cord blood (Kern et al., 2006).
Mesenchymal cells are one of the major
components of a variety of tissues and
are critical for establishing tissue organi-
zation and response to injury. We know
that MSCs isolated from different organs
and tissues display similar morphology
and phenotype, share an ability to prolif-
erate substantially in vitro, and differen-
tiate to multiple cell types. However, we
still know little about the origin and the
distinct functional properties of tissue-
specific mesenchymal cells and the hier-
archy of mesenchymal progenitors. In
this current issue, Chong et al. (2011)
chose to ask whether the heart contains
CFU-Fs and, if so, where they originate.
Using a noncardiomyocyte population of
cells isolated from mouse hearts and
standard conditions for CFU-F detection,
they demonstrated that embryonic and
adult hearts contain CFU-F cells with
long-term in vitro expansion potential.
These cardiac-derived MSCs exhibited
multipotency in vitro and in vivo for meso-
dermal lineages, including smooth
muscle, bone, cartilage, adipose, endo-
thelial, and a-actinin+ striated cardiac-
type muscle cells. These so-called
cardiac CFU-F (cCFU-F) cells were
capable of contributing to nonmesoder-
mal lineage cells within teratomas
when cotransplanted with ESCs. Using492 Cell Stem Cell 9, December 2, 2011 ª20Pdgfra/GFP knockin mice, immunostain-
ing, and cell sorting, the authors demon-
strated that cCFU-Fs expressed PDGFRa
MSC marker and SCA1 stem cell marker
but essentially lacked expression of
another stem cell marker, cKIT, as well
as endothelial (CD31, FLK1), hematopoi-
etic (CD45), cardiac (NKX2-5), and ESC-
specific (Sox2, Rex1, Nanog, and Klf4)
molecules.
Because two major germ layers (meso-
derm and neural crest/ectoderm) con-
tribute to mesenchymal cells during
embryonic development, Chong et al.
(2011) used Mesp1 (mesodermal) and
Wnt1 (neural crest) Cre-recombinase
lineage tracing to define the source of
cCFU-Fs. These experiments revealed
that cCFU-Fs originate from mesoderm
but not from neural crest. Additional
lineage tracing experiments using Wt1-
Cre and Gata5-Cre epicardial lineage
andMyl2-CreandNkx2-5-Crecardiomyo-
cyte lineage tags found that cCFU-Fs
arise from proepicardium and epicardium
but not from cardiomyocytes. Despite
similar phenotype and molecular signa-
ture, cCFU-Fs displayed a CRE lineage
signature distinct from bone marrow
CFU-Fs, indicating that organ-specific
MSCs have diverse postgastrulation
origins.
Recently, the epicardium has been
recognized as a source of cardiovascular
progenitors during embryogenesis and
postnatal life. A subset of epicardial
mesothelial cells expressingWt1 undergo
endothelial-mesenchymal transition
(EMT) and contribute to interstitial fibro-
blasts, vasculature, and cardiomyocytes
(Smart et al., 2011; Zhou et al., 2008).
These cells are defined as epicardium-
derived cells (EPDCs) (Gittenberger-de
Groot et al., 1998). However, the distinct
steps in EMT transition and hierarchy of11 Elsevier Inc.progenitors formed during transition
remain unclear. Chong et al. (2011) found
that at least some cells undergoing EMT
acquire CFU-F potential and contribute
predominately to cellular elements of the
cardiac interstitium and vasculature. In
addition, Limana et al. (2007) demon-
strated that epicardium contains cKIT+
progenitors, which participate in myocar-
dial regeneration and are capable of
generating mesenchymal cells after
culture in vitro. These progenitors seem
different form cCFUs because they
express Nkx2-5 cardiac marker and
cKIT. However, the origin of epicardial
cKIT+ cells is unclear. It has been sug-
gested that these cells represent the
earliest step of EMT or interstitial Cajal-
like cells.
The epicardium is not the sole source
of mesenchymal cells in the heart; the
endocardium and neural crest also
contribute to the mesenchymal popula-
tion within the developing heart. Similar
to epicardial mesothelium, endocardial
endothelial cells undergo endothelial-
mesenchymal transition and contribute
to endocardial cushions, the primary atrial
septum, and leaflets of the atrio-ventric-
ular valves in thepostnatal heart (de Lange
et al., 2004). Neural-crest-derived mesen-
chymal cells are essential for development
of aortico-pulmonary septum and truncal
ridges (Hutson and Kirby, 2007). Thus,
complete characterization of the mesen-
chymal cell populations in the heart would
require an analysis of the contribution of
endocardium and neural crest to CFU-Fs
in the heart and major vessels. In the
present study, Chong et al. (2011) have
reported that the aorta contains CFU-Fs
originating from the neural crest.
However, endocardial cushions and adult
valve leaflets yielded few small CFU-Fs
with limited expansion potential. Although
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may not contribute significantly to cardiac
CFU-Fs, the possibility remains that
CFU-Fs of endocardial origin may be
functionally different from epicardial
CFU-Fs and require a different cell culture
medium for optimal detection.
Understanding the developmental bi-
ology of the heart is instrumental in
developing novel technologies for heart
regeneration and cellular therapies. It is
critical to identify the type and origin of
cells capable of reconstituting a heart.
To determine whether a cardiac mesen-
chymal cell compartment could be recon-
stituted by bone marrow cells after injury,
Chong et al. (2011) performed CFU-F
evaluation in the heart after transplanta-
tion of bone marrow cells following
myocardial infarction, irradiation, and
hematopoietic stem cell immobilization.
While the authors found that bonemarrow
cells could reconstitute themarrowCFU-F
compartment, they failed to detect their
contribution to cardiac CFU-Fs. These
findings support the view that bone
marrow cells do not reconstitute cardiac
cells after cardiac injury. In this context,
the activation of cardiac resident progen-
itors could be considered as a reasonable
approach to promote cardiac tissue
regeneration and vessel growth. Recentwork by Smart et al. (2011) found that
expression of embryonic epicardial
progenitor marker Wt1 can be activated
in the adult epicardium by stimulation
with thymosin b4 prior to myocardial
infarction. Subsequently, these cells
migrate into the heart and contribute to
smooth and cardiac muscles and intersti-
tial fibroblasts. Further work will be
required to determine the relationship
between epicardial progenitors described
by Smart and colleagues (Smart et al.,
2011) and cCFU-Fs identified by Chong
and colleagues (Chong et al., 2011). Do
they represent similar or hierarchically
related progenitors? Are there any stimuli
that can activate cCFU-Fs and facilitate
cardiac repair and vascularization after
myocardial infarction? Since repair
consists of a combination of regeneration
and scar formation, it is important to
determine the contribution of cCFU-Fs
to postinfarct scar formation and whether
improvement in restoration of cardiac
function can be achieved by modulation
of sclerogenic versus tissue-forming
response of cCFU-Fs. Certainly, the find-
ings presented by Chong et al. (2011)
introduce several interesting and novel
avenues of investigation, particularly in
the context of cardiac regenerative
therapies.Cell Stem Cell 9,REFERENCES
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Regulation of hematopoietic stem cell (HSC) dormancy by specific cell types in the hematopoietic niche
remains poorly understood. Yamazaki et al. (2011) now report that nerve-associated nonmyelinating
Schwann cells activate TGF-b to maintain dormant HSCs, suggesting that glia are novel players in the
bone marrow niche.Hematopoietic stem cells (HSCs) reside in
specialized microenvironments, or niches,
that ensure their localization, survival, con-
trolled proliferation, and differentiation.Components of the bone marrow (BM)
hematopoietic niche includemesenchymal
stem cells (MSCs), which secrete HSC
homing and maintenance factors; osteo-blasts, which derive from MSCs and line
the surface of the endosteum on the inside
of the bone cavity; and sympathetic nerve
fibers, which coordinate hematopoieticDecember 2, 2011 ª2011 Elsevier Inc. 493
